3859 results for «435»
3859 results
EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- A randomized study comparing imaging guided implantation of Orsiro and Xience: the CASTLE study
- Impact of different optimal stent implantation definitions in OCT-guide PCI
- Risk-stratification in ACS by comprehensive morphofunctional assessment with OCT
- 7.5 years follow-up after OCT-guided PCI: report...
EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- Angiography based Fractional Flow Reserve: the FAST II trial
- Instantaneous wave-free ratio for the assessment of nonculprit lesions
- Capacity of the PPG to predict functional revascularisation
- Clinical impact of FFR guided PCI
EAPCI-PCR Fellows Course 2021 - Coronary track: Radial approach/Coronary angiogram
14 Apr 2021 – From EuroPCR 2021
The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at the beginning of their careers. Education and networking are at the core of the building of future careers powered by...
Emergency cases in the cathlab: there is not just ACS and PCI
18 May 2021 – From EuroPCR 2021
Look at this video presenting a patient with massive bilateral central pulmonary embolism: how would you treat?
Uncrossable lesions
18 May 2021 – From EuroPCR 2021
Thanks to this session, get to know how to treat an uncrossable lesion, and especially in patients with inferior STEMI.
Surgery or PCI?
18 May 2021 – From EuroPCR 2021
In this session, discover a case when the surgeon ́s ambitions are higher than his courage.
Which way to choose?
18 May 2021 – From EuroPCR 2021
Watch this video to check whether you would have opted for the same vessel and the same strategy when facing this NSTEMI case.
A low-risk patient with a bicuspid type 0 aortic stenosis
18 May 2021 – From EuroPCR 2021
How would you treat an 82-year-old male patient presented with dyspnoea NYHA III who is also found to have IPMN? View this session to analyze the authors' decision!
Two emergencies in one time
18 May 2021 – From EuroPCR 2021
What happened to this 47-year-old man who was still restless, hypoxic, tachypenic, and dependent on oxygen and inotrope even after excellent PCI results? Watch this session to find out more!
Acute STEMI, coronary ectasia and large thrombus burden
18 May 2021 – From EuroPCR 2021
In this session, discover why the combination of DOAC's and DAPT have promising role in the management of large thrombus and coronary ectasia.
Case-based challenging heart team decisions in combined structural heart diseases
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this case-based session on combined structural heart diseases to discover what is the heart team approach for complex structure heart diseases, as well as how to manage a patient with multiple diseases.
Edge-to-edge mitral repair
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on edge-to-edge mitral repair to learn more about the indication and the patient selection for percutaneous mitral valve treatment for secondary MR, and discover some interesting tips and tricks in difficult situations during MitraClip.
Update on new guidelines for management of patients with valvular heart disease
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on the management of patients with valvular heart disease to learn about the new guidelines, and discover how to apply them to your daily practice.
TAVI and coronary artery disease
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.
Valve-in-valve TAVI
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on valve-in-valve TAVI to learn how to identify patient at risk of coronary obstruction and PPM post VIV procedure, and discover how to protect the coronary arteries and how to minimise PPM during the surgery.
Case-based challenging TAVI
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations.
Tailoring mitral repair and optimising clinical outcomes using MitraClip G4
27 Sep 2021 – From PCR Tokyo Valves 2021
Using the one-year results of the EXPAND study and the 30-day results of the EXPAND G4 study, this session highlights the value of the latest generation of MitraClip technologies, providing an overview of the strengths of the MitraClip G4 and its practical use on 2 case...
Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with a case-based heart team discussion to learn more about the treatment of aortic stenosis in patients with longer life expectancy: discover what the 2021 guidelines say about patient selection, what should be considered for patients with longer life expectancy, and how to optimise procedural outcome.
The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis
18 May 2022 – From EUROPCR 2022
This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.
Why durability matters: lifetime management considerations for supra-annular TAVR
26 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...
